UnitedHealth Group (UNH) Declines More Than Market: Some Information for Investors

Company Performance - UnitedHealth Group (UNH) ended the recent trading session at $302.01, showing a -1.69% change from the previous day's closing price, which lagged behind the S&P 500's daily loss of 0.22% [1] - Shares of UnitedHealth Group had gained 3.55% in the past month, while the Medical sector remained flat with a 0% change, and the S&P 500 gained 0.45% during the same period [1] Earnings Forecast - UnitedHealth Group is scheduled to release its earnings on July 29, 2025, with a forecasted EPS of $5.16, indicating a 24.12% decrease from the same quarter of the previous year [2] - The consensus estimate for revenue is $111.93 billion, reflecting a 13.23% growth compared to the corresponding quarter of the prior year [2] Full Year Estimates - For the full year, analysts expect earnings of $22.28 per share and revenue of $449.69 billion, representing changes of -19.45% and +12.34%, respectively, from the previous year [3] - Recent changes to analyst estimates suggest a positive outlook for the business, as revisions often reflect near-term business trends [3] Stock Performance and Valuation - The Zacks Rank system indicates that UnitedHealth Group currently holds a rank of 5 (Strong Sell), with the consensus EPS estimate moving 2.64% lower over the past month [5] - UnitedHealth Group is trading at a Forward P/E ratio of 13.79, which is a premium compared to the industry average Forward P/E of 13.1 [6] - The company has a PEG ratio of 1.44, while the average PEG ratio for the Medical - HMOs industry is 0.96 [6] Industry Overview - The Medical - HMOs industry is part of the Medical sector and holds a Zacks Industry Rank of 97, placing it in the top 40% of over 250 industries [7] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]